Advanced Filters
noise
Found 1,144 clinical trials
Q Qianqian Xin

Improvement of Depression With Use of ATP

This clinical study is a randomized, double-blind, placebo-controlled trial with an intervention period of 4 weeks. Participants will be patients with moderate to severe depression who meet the inclusion criteria during the screening period. After recruitment written informed consent form will be signed and the baseline evaluation will be done …

18 - 65 years of age All Phase N/A
W Walker SH Au

Evaluation Study of Medical-Social Collaboration Model for Middle-aged and Older Adults With Depressive Symptoms

The goal of this clinical trial is to learn if a medical-social collaboration model works to reduce depressive symptoms in middle-aged and older adults with subsyndromal depressive symptoms who are waiting for their first psychiatric appointment. Secondary outcomes of the study include reduced anxiety symptoms, reduced loneliness, reduced rumination, reduced …

45 years of age All Phase N/A
C Carol S Johnston, PhD

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement …

16 - 65 years of age All Phase N/A
A Aleeza West

Training Reward Responsiveness Through Virtual Reality

The purpose of this study is to compare the effects of Virtual Reality-Reward Training (VR-RT) with an active control condition, Virtual Reality-Memory Training (VR-MT), on positive affect and other clinical symptoms. VR-Reward Training is a novel intervention aimed at enhancing savoring of positive experiences among individuals with depression and low …

18 years of age All Phase 2
M Mei chen Liu

DPA-714 and FDG PET/MRI in Depression

Depression, a common psychological disorder, is characterized by persistent low mood, loss of interest, and anhedonia, leading to significant dysfunctions and a high suicide risk. Its pathogenesis remains challenging, with recent focus on neuroinflammation-a chronic immune response in the central nervous system-as a potential contributor. PET imaging, using tracers like …

35 - 85 years of age All Phase N/A
J Jonathan P Roiser, PhD

Mechanisms Underlying Antidepressant Effects of Physical Activity

It is well established that any level of physical activity can help prevent and treat depression, with more strenuous activity having a greater effect. Understanding the mechanisms driving this antidepressant effect is important because it could allow exercise programmes to be made more effective, accessible, and targeted. Such knowledge could …

18 - 60 years of age All Phase N/A

Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression

Major depressive disorder (MDD) is a mood disorder characterized primarily by low mood, diminished interest, and reduced energy. Traditional views considered depression a non-degenerative condition; however, recent epidemiological studies have revealed its significant association with impaired social functioning. Data indicate that 59.3% of patients with depression experience social dysfunction of …

16 - 65 years of age All Phase N/A
M Mostafa M Bahaa, PhD

Dapagliflozin in Depression

Major depressive disorder (MDD) is currently one of the leading causes of disability and suicidal death worldwide, and despite extensive research and massive improvements in mental health, the nature of MDD remains ambiguous. Moreover, about two-thirds of MDD patients fail to optimally respond to currently available standard therapies, and many …

18 - 60 years of age All Phase 1/2
M Manuel Morrens

INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder

This is a randomised, double-blind, placebo-controlled clinical trial in which patients with major depressive disorder will receive augmentation through minocycline (MCO), celecoxib (CXB) or placebo.

18 - 65 years of age All Phase 3
J Jovi Koh

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.

21 years of age All Phase N/A

Simplify language using AI